0085-1177 : Integrilin 2 mg/ml Intravenous Injection, Solution
NDC: | 0085-1177 |
Labeler: | Merck Sharp & Dohme Corp. |
Product Type: | Human Prescription Drug |
Drug Name: | Integrilin |
Dosage Form: | Intravenous Injection, Solution |
Application #: | NDA020718 |
Rev. Date: |
NDC Package Codes:
- 0085-1177-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (0085‑1177‑01) > 10 ML IN 1 VIAL, SINGLE‑USE
- 0085-1177-02: 1 VIAL, SINGLE‑USE IN 1 CARTON (0085‑1177‑02) > 100 ML IN 1 VIAL, SINGLE‑USE
- 0085-1177-03: 1 VIAL, SINGLE‑USE IN 1 CARTON (0085‑1177‑03) > 10 ML IN 1 VIAL, SINGLE‑USE
- 0085-1177-05: 1 VIAL, SINGLE‑USE IN 1 CARTON (0085‑1177‑05) > 10 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Eptifibatide
Dosage Strength:
- 2 mg/mL
Pharmaceutical Classes:
- Decreased Platelet Aggregation [PE]
- Platelet Aggregation Inhibitor [EPC]
Related Products:
Based on records with the same trade name.- 0085-1136 Integrilin .75 mg/ml Intravenous Injection, Solution by Merck Sharp & Dohme Corp.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0085-1168Next: 0085-1194 >
Related Discussions:
integrilin
miocardial infarction...
miocardial infarction...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.